Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Hudbay

<< Previous

Bullboard Posts

Next >>

Comment by waynedon Aug 12, 2011 9:53pm

215 Views

Post# 18938228

RE: RE: RE: Hudbay

I think they have 3 IR firms on the go at last count. All were paid in monthly cash and shares. Buried deep in their reporting a year or so ago was a mission statement that the company would be open and transparent to all shareholders . What a cruel joke that is. I guess there is always the annual meeting but you can never organize retail shareholder and all these junior mining crooks know that . Kind of like Harper`s attitude. Ignore them and they will quickly go away.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages